Combination Immunotherapy in Rare Cancers Under InvesTigation

Clinical trial NCT04969887 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04969887
Sponsor: Olivia Newton-John Cancer Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Biliary Tract Cancer Neuroendocrine Tumors Female Reproductive System Neoplasm MSI-H Solid Malignant Tumor

Start date: 2021-08-03
Primary completion: 2025-03-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.